Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032)
在既往接受过治疗的胰腺腺癌患者中,使用纳武利尤单抗单药治疗或联合伊匹木单抗(可联合或不联合考比替尼)治疗(CheckMate 032)
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2023-007883
Callahan, Margaret; Amin, Asim; Kaye, Frederic J; Morse, Michael A; Taylor, Matthew H; Peltola, Katriina J; Sharma, Padmanee; O'Reilly, Eileen M; Meadows Shropshire, Stephanie; O'Brien, Shaun; Tschaika, Marina; Le, Dung T